Pharma Co. Earns Big Rewards from Global License Deal
Source: Streetwise Reports  (11/2/22)
Kiniksa Pharmaceuticals Ltd. shares traded 12% higher yesterday after the company reported Q3/22 financial results that included a 720% YoY increase in net revenue attributed to a combination of organic growth and increases in global licensing revenue. More >

The 'Bear Killer' Does it Again
Source: Michael Ballanger  (11/1/22)
Expert Michael Ballanger reviews recent updates in the stock market to tell you where he believes it is headed and why he thinks October was "The Bear Killer," with countless bear markets ending and bull markets possibly beginning today, November 1, 2022. More >

PFS on Rare Earth Co.'s B.C. Project Expected to be 'Robust'
Source: Mark Reichman  (11/1/22)
With this season's drilling behind it, the Canadian explorer plans to start, by year-end, the next step in advancing its project, noted a Noble Capital Markets report. More >

Biopharma Co. Trades 39% Higher
Source: Streetwise Reports  (11/1/22)
Actinium Pharmaceuticals Inc. shares traded 39% higher yesterday to a new 52-week high after the firm reported topline data from its Phase 3 SIERRA study of Iomab-B in patients with active relapsed or refractory acute myeloid leukemia. During the pivotal trial, Iomab-B met its primary pre-established endpoint of durable complete remission or dCR of six months post-initial remission following a bone marrow transplant. More >

Gold Is At/Near a Bottom, Let's Make Over 5% Yield With Newmont While We Wait
Source: Ron Struthers   (11/1/22)
The decline in gold prices will not last forever, and we just witnessed a double bottom and now heard Central Banks are buying at a record pace. Newmont mining is expert Ron Struthers' go-to stock when gold prices start to move, and he believes it currently offers great value with an over 5% dividend yield. More >

Newly Found Feeder Zone at Gold Project to Benefit Mine Plan
Source: Mike Niehuser  (11/1/22)
The high-grade and mineable widths of this zone will likely improve the economics of the future mining operation in Fiji, noted a ROTH Capital Partners report. More >

Expert Michael Ballanger's Top Picks
Source: Michael Ballanger  (10/31/22)
Expert Michael Ballanger reviews updates from some major junior mining companies, such as Getchell Gold Corp. and Norseman Silver, among others, to tell you his opinion on each company and where junior mining is heading as a sector. More >

Biopharma Gains Two Cancer Cell Therapy Programs and a Target Price 10 Times Current
  (10/31/22)
This developer of cancer immunotherapies will take possession of these clinical-stage assets in a transaction with GSK and subsequently advance them toward approval, noted a ROTH Capital Partners report. More >

Nestle Continues To Execute as Profits Grow
Source: Adrian Day  (10/31/22)
Today expert Adrian Day discusses results from two core holdings, both doing well, according to him, despite cost inflation. Day believes you can use current weakness to accumulate a portfolio of blue chips.
More >

Precious Metals Sector Believed To Be Close to Major Uptrend
Source: Clive Maund  (10/31/22)
With the possibility of a Fed pivot looming, expert Clive Maund touches on his views of the precious metals sector and why he believes you should invest in it sooner rather than later. More >

Junior Sees 'Very Encouraging' Results From Nevada Drilling
Source: Streetwise Reports  (10/28/22)
The results from the first two holes of a nine-hole drilling campaign at this company's Nevada flagship project have surpassed expectations. More >

Robotics-Driven Services Co. Posts 20% Revenue Gains in Q3
Source: Streetwise Reports  (10/28/22)
Shares of Oceaneering International Inc. traded 16.5% higher yesterday after the diversified offshore engineering services and manufacturing firm reported Q3/22 financial results that included a 20% YoY increase in revenue and improved operating performance and profitability across all its business units. More >

Drilling Reveals Deep Mineralization at Colombia Project
Source: Streetwise Reports  (10/28/22)
Outcrop Silver & Gold Corp. is reporting its deepest high-grade mineralization to date at its Santa Ana project in Colombia. More >

Biotech Co. Achieves High ORRs in Ph. 1 NSCLC Trial
Source: Streetwise Reports  (10/28/22)
Shares of Nuvalent Inc. traded 60% higher to a new 52-week intraday high after the company reported initial data from its Phase 1 ARROS-1 trial of NVL-520 demonstrating positive objective response rates in patients with ROS1-Positive non-small cell lung cancer. More >

Potential ROI With German Biopharma Co. Notable
Source: Dr. Elemer Piros  (10/27/22)
This firm, with eight treatment candidates for mental health disorders in development, boasts a catalyst-rich next two months, noted a ROTH Capital Partners report. More >

Restaurant Chain Boosts Same-Store Sales by 6.9% in Q3
Source: Streetwise Reports  (10/27/22)
Shares of Wingstop Inc. traded 15% higher yesterday after the company reported that during Q3/22, it opened 40 net new restaurants and increased its system-wide sales by 17.7%. In addition, the company raised its FY/22 earnings guidance. More >

Copper: The Most Important Metal We're Running Short Of
Source: Rick Mills  (10/27/22)
With global interest and use of copper rising, copper may not be able to meet demand. Expert Rick Mills of Ahead of the Herd reviews the demand for copper, the push for more infrastructure, and what he believes the future holds for this metal. More >

CRO Firm's Shares Rise on Q3 Earnings and Growth Prospects
Source: Streetwise Reports  (10/26/22)
Shares of full-service clinical contract research organization Medpace Holdings Inc. traded 37% higher yesterday after the company reported Q3/22 financial results that included a nearly 30% YoY increase in revenue. More >

Vaccine Co. Posts Positive Ph. 1/2 IPD Trial Results
Source: Streetwise Reports  (10/25/22)
Shares of Vaxcyte Inc. traded 61% higher yesterday to a new 52-week high after the company reported positive topline results from its Phase 1/2 study of VAX-24, its novel 24-valent pneumococcal conjugate vaccine candidate being developed to prevent invasive pneumococcal disease in adults 18 to 64 years of age. More >

Expert Says Buy Pharma Co. Stock 'as Soon as Possible'
Source: Clive Maund  (10/25/22)
Algernon Pharmaceuticals has entered into a clinical trial agreement with Yale and caught expert Clive Maund's attention. In light of this, Maund reviews the company's chart to tell you when he believes you should buy its stock. More >

Florida Co. Partners To Create First Sustainable PP Resin
Source: Streetwise Reports  (10/24/22)
Shares of PureCycle Technologies Inc. traded 8% higher Friday after the company reported that together with Milliken & Co. of Belgium it has created a new concentrate using recycled polypropylene (PP) resin that advances circularity and reduces GHG emissions by 35%. Thursday, PureCycle announced it formed a JV with SKGC of South Korea to build the first PP recycling plant in Asia. More >

Drilling Reveals High-Grade Silver Mineralization and District-Scale Potential in Europe
Source: Streetwise Reports  (10/24/22)
Terra Balcanica's drill results demonstrate the potential of a high-grade silver-zinc-gold deposit. More >

Is This the Vaunted Fed Pivot?
Source: Clive Maund  (10/24/22)
Expert Clive Maund believes the Fed may pivot soon. Read to find out why he believes this is true and where he thinks the market is heading. More >

Six Resource Companies You Should Pay Attention To
Source: Adrian Day  (10/24/22)
Several resource companies on expert Adrian Day's list have reported their production numbers for the third quarter, with some positive surprises, though costs are rising. More >

Biopharma Co. Shows Large Potential Return
Source: Dr. Joseph Pantginis   (10/21/22)
Palatin Technologies Inc.'s third-party clinical trial of Vyleesi in women with hypoactive sexual desire disorder was just published in the Journal of Clinical Investigation, and the biopharma offers investors significant potential return, noted an H.C. Wainwright & Co. report. More >